Dr. Grosser is an expert in the biology and human pharmacology of cyclooxygenase (COX) inhibitors, non-steroidal antiinflammatory drugs (NSAIDs) with and without selectivity for COX-2. He applies high-throughput technology, including proteomics methodology, to studies of drug safety and interindividual variation in drug response.